159 related articles for article (PubMed ID: 37819535)
1. Targeting TNFAIP2 induces immunogenic cell death and sensitizes glioblastoma multiforme to anti-PD-1 therapy.
Hou C; Shi S; Gao M; Ji J; Ma C; Wang T; Chen T; Liu Y; Zhong J; Zheng Y; Ye J; Ke Y
J Neurooncol; 2023 Oct; 165(1):79-90. PubMed ID: 37819535
[TBL] [Abstract][Full Text] [Related]
2. Curcumin Enhanced Ionizing Radiation-Induced Immunogenic Cell Death in Glioma Cells through Endoplasmic Reticulum Stress Signaling Pathways.
Xiu Z; Sun T; Yang Y; He Y; Yang S; Xue X; Yang W
Oxid Med Cell Longev; 2022; 2022():5424411. PubMed ID: 36238646
[TBL] [Abstract][Full Text] [Related]
3. IGFBP3 induces PD-L1 expression to promote glioblastoma immune evasion.
Zhao L; Wang Y; Mu P; Zhang X; Qi R; Zhang Y; Zhang H; Zhu X; Dong Z; Dong Y
Cancer Cell Int; 2024 Feb; 24(1):60. PubMed ID: 38326861
[TBL] [Abstract][Full Text] [Related]
4. Combination Therapy with Anti-PD-1, Anti-TIM-3, and Focal Radiation Results in Regression of Murine Gliomas.
Kim JE; Patel MA; Mangraviti A; Kim ES; Theodros D; Velarde E; Liu A; Sankey EW; Tam A; Xu H; Mathios D; Jackson CM; Harris-Bookman S; Garzon-Muvdi T; Sheu M; Martin AM; Tyler BM; Tran PT; Ye X; Olivi A; Taube JM; Burger PC; Drake CG; Brem H; Pardoll DM; Lim M
Clin Cancer Res; 2017 Jan; 23(1):124-136. PubMed ID: 27358487
[TBL] [Abstract][Full Text] [Related]
5. Temozolomide-based sonodynamic therapy induces immunogenic cell death in glioma.
Zhou Y; Jiao J; Yang R; Wen B; Wu Q; Xu L; Tong X; Yan H
Clin Immunol; 2023 Nov; 256():109772. PubMed ID: 37716612
[TBL] [Abstract][Full Text] [Related]
6. Immunovirotherapy with measles virus strains in combination with anti-PD-1 antibody blockade enhances antitumor activity in glioblastoma treatment.
Hardcastle J; Mills L; Malo CS; Jin F; Kurokawa C; Geekiyanage H; Schroeder M; Sarkaria J; Johnson AJ; Galanis E
Neuro Oncol; 2017 Apr; 19(4):493-502. PubMed ID: 27663389
[TBL] [Abstract][Full Text] [Related]
7. Carbon ion radiotherapy triggers immunogenic cell death and sensitizes melanoma to anti-PD-1 therapy in mice.
Zhou H; Tu C; Yang P; Li J; Kepp O; Li H; Zhang L; Zhang L; Zhao Y; Zhang T; Sheng C; Wang J
Oncoimmunology; 2022; 11(1):2057892. PubMed ID: 35355680
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-184 inhibits cell proliferation and invasion, and specifically targets TNFAIP2 in Glioma.
Cheng Z; Wang HZ; Li X; Wu Z; Han Y; Li Y; Chen G; Xie X; Huang Y; Du Z; Zhou Y
J Exp Clin Cancer Res; 2015 Mar; 34(1):27. PubMed ID: 25888093
[TBL] [Abstract][Full Text] [Related]
9. Molecular and functional analysis of tyrosinase-related protein (TRP)-2 as a cytotoxic T lymphocyte target in patients with malignant glioma.
Liu G; Khong HT; Wheeler CJ; Yu JS; Black KL; Ying H
J Immunother; 2003; 26(4):301-12. PubMed ID: 12843792
[TBL] [Abstract][Full Text] [Related]
10. 4-1BB Agonism Averts TIL Exhaustion and Licenses PD-1 Blockade in Glioblastoma and Other Intracranial Cancers.
Woroniecka KI; Rhodin KE; Dechant C; Cui X; Chongsathidkiet P; Wilkinson D; Waibl-Polania J; Sanchez-Perez L; Fecci PE
Clin Cancer Res; 2020 Mar; 26(6):1349-1358. PubMed ID: 31871298
[TBL] [Abstract][Full Text] [Related]
11. A biologic-device combination product delivering tumor-derived antigens elicits immunogenic cell death-associated immune responses against glioblastoma.
Cultrara C; Uhl C; Kirby K; Abed Elrazaq E; Zellander A; Andrews DW; Scott CB; Galluzzi L; Exley MA; Zilberberg J
J Immunother Cancer; 2023 Aug; 11(8):. PubMed ID: 37550054
[TBL] [Abstract][Full Text] [Related]
12. CD137 and PD-L1 targeting with immunovirotherapy induces a potent and durable antitumor immune response in glioblastoma models.
Puigdelloses M; Garcia-Moure M; Labiano S; Laspidea V; Gonzalez-Huarriz M; Zalacain M; Marrodan L; Martinez-Velez N; De la Nava D; Ausejo I; Hervás-Stubbs S; Herrador G; Chen Z; Hambardzumyan D; Patino Garcia A; Jiang H; Gomez-Manzano C; Fueyo J; Gállego Pérez-Larraya J; Alonso M
J Immunother Cancer; 2021 Jul; 9(7):. PubMed ID: 34281988
[TBL] [Abstract][Full Text] [Related]
13. Gold standard assessment of immunogenic cell death induced by photodynamic therapy: From in vitro to tumor mouse models and anti-cancer vaccination strategies.
Mishchenko TA; Balalaeva IV; Turubanova VD; Saviuk MO; Shilyagina NY; Krysko O; Vedunova MV; Krysko DV
Methods Cell Biol; 2024; 183():203-264. PubMed ID: 38548413
[TBL] [Abstract][Full Text] [Related]
14. Combined acetyl-11-keto-β-boswellic acid and radiation treatment inhibited glioblastoma tumor cells.
Conti S; Vexler A; Edry-Botzer L; Kalich-Philosoph L; Corn BW; Shtraus N; Meir Y; Hagoel L; Shtabsky A; Marmor S; Earon G; Lev-Ari S
PLoS One; 2018; 13(7):e0198627. PubMed ID: 29969452
[TBL] [Abstract][Full Text] [Related]
15. Newcastle disease virotherapy induces long-term survival and tumor-specific immune memory in orthotopic glioma through the induction of immunogenic cell death.
Koks CA; Garg AD; Ehrhardt M; Riva M; Vandenberk L; Boon L; De Vleeschouwer S; Agostinis P; Graf N; Van Gool SW
Int J Cancer; 2015 Mar; 136(5):E313-25. PubMed ID: 25208916
[TBL] [Abstract][Full Text] [Related]
16. Nanomicelle protects the immune activation effects of Paclitaxel and sensitizes tumors to anti-PD-1 Immunotherapy.
Yang Q; Shi G; Chen X; Lin Y; Cheng L; Jiang Q; Yan X; Jiang M; Li Y; Zhang H; Wang H; Wang Y; Wang Q; Zhang Y; Liu Y; Su X; Dai L; Tang M; Li J; Zhang L; Qian Z; Yu D; Deng H
Theranostics; 2020; 10(18):8382-8399. PubMed ID: 32724476
[TBL] [Abstract][Full Text] [Related]
17. Resveratrol targeting of AKT and p53 in glioblastoma and glioblastoma stem-like cells to suppress growth and infiltration.
Clark PA; Bhattacharya S; Elmayan A; Darjatmoko SR; Thuro BA; Yan MB; van Ginkel PR; Polans AS; Kuo JS
J Neurosurg; 2017 May; 126(5):1448-1460. PubMed ID: 27419830
[TBL] [Abstract][Full Text] [Related]
18. Combination of hyaluronic acid conjugates with immunogenic cell death inducer and CpG for glioblastoma local chemo-immunotherapy elicits an immune response and induces long-term survival.
Catania G; Rodella G; Vanvarenberg K; Préat V; Malfanti A
Biomaterials; 2023 Mar; 294():122006. PubMed ID: 36701998
[TBL] [Abstract][Full Text] [Related]
19. Evidence of immunogenic cancer cell death induced by honey-processed Astragalus polysaccharides in vitro and in vivo.
Sha X; Xu X; Liao S; Chen H; Rui W
Exp Cell Res; 2022 Jan; 410(1):112948. PubMed ID: 34826423
[TBL] [Abstract][Full Text] [Related]
20. Blocking Wnt/β-catenin Signal Amplifies Anti-PD-1 Therapeutic Efficacy by Inhibiting Tumor Growth, Migration, and Promoting Immune Infiltration in Glioblastomas.
Zhang H; Bi Y; Wei Y; Liu J; Kuerban K; Ye L
Mol Cancer Ther; 2021 Jul; 20(7):1305-1315. PubMed ID: 34001635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
